The Association of the British Pharmaceutical Industry

Medicines are transforming our lives like never before. We want the UK to be the best place in the world to research, develop and use the medicines of the future.


Facts and Figures


Online members portal

My ABPI members can log in for bespoke content and services



23 February 2021

ABPI response to NHS Commercial Framework

The NHS Commercial Framework for New Medicines has been published.

19 February 2021

ABPI response to EU data adequacy decision

The European Commission has issued a positive preliminary data adequacy decision for the UK which will allow data to continue to flow freely from the EU to the UK.

15 February 2021

ABPI response to Life Science Competitiveness Indicators

The government has published new data on the life science sector in the UK and other countries.

15 February 2021

Eight industry leaders call on Chancellor to reform outdated R&D rules

The Chancellor is being urged by a coalition of top industry leaders to kickstart the recovery and levelling up by allowing capital expenditure to qualify for R&D tax credits. 



17 February 2021

There’s nothing we can’t do or achieve, but people with thalassaemia need understanding and support

Thalassaemia major is a serious, genetic blood disorder. Roanna Maharaj was diagnosed with a severe form of the disease as a baby in the Caribbean. This is her story.

17 February 2021

Evolving the UK health system to support innovation for the rare disease community

Nicola Redfern, General Manager of bluebird bio in the UK, describes the commercial challenges for rare disease medicines in the UK and reflects on the opportunities of gene therapies.